Solid Biosciences Inc.

SLDB · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$80,235$74,015$155,384$119,136
Short-Term Investments$68,685$49,625$58,338$88,643
Receivables$0$0$0$110
Inventory$0$0$0$0
Other Curr. Assets$8,382$6,094$5,916$14,723
Total Curr. Assets$157,302$129,734$219,638$222,612
Property Plant & Equip (Net)$29,042$33,163$38,606$7,604
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$2,318$2,042$2,008$2,164
Total NC Assets$31,360$35,205$40,614$9,768
Other Assets$0$0$0$0
Total Assets$188,662$164,939$260,252$232,380
Liabilities
Payables$4,237$2,032$3,238$4,463
Short-Term Debt$3,018$2,324$2,565$1,495
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$8,080
Other Curr. Liab.$23,002$10,161$16,705$9,563
Total Curr. Liab.$30,257$14,517$22,508$23,601
LT Debt$21,159$23,941$25,982$568
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$96$0
Total NC Liab.$21,159$23,941$26,078$568
Other Liabilities$0$0$0$0
Cap. Leases$24,177$26,265$28,547$2,063
Total Liabilities$51,416$38,458$48,586$24,169
Equity
Pref Stock$0$0$0$0
Common Stock$40$20$20$7
Retained Earnings-$783,450-$658,753-$562,738-$476,757
AOCI$47$15-$68-$45
Other Equity$920,609$785,199$774,452$685,006
Total Equity$137,246$126,481$211,666$208,211
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$188,662$164,939$260,252$232,380
Net Debt-$56,058-$47,750-$126,837-$117,073